UNITED THERAPEUTICS Corp Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 358.88M592.90M743.18M916.08M1,116.98M1,288.50M1,465.80M1,598.80M1,725.30M1,627.80M1,448.80M1,483.30M1,685.50M1,936.30M2,327.50M2,877.40M
Cost of Revenue 40.86M67.67M88.90M119.30M131.13M125.90M69.00M72.70M105.70M198.70M117.60M108.10M122.50M151.60M257.50M309.70M
Gross Profit 318.02M525.23M654.28M796.78M985.86M1,162.60M1,396.80M1,526.10M1,619.60M1,429.10M1,331.20M1,375.20M1,563.00M1,784.70M2,070.00M2,567.70M
Operating items
Research & Development 120.37M165.31M180.01M173.39M299.35M242.50M245.10M147.60M264.60M357.90M1,182.60M357.70M540.10M322.90M408.00M481.00M
Selling, General & Administrative 171.89M188.61M156.48M201.75M394.01M381.30M452.70M316.80M330.10M265.80M467.00M482.10M477.10M709.70M
Other Operating Expenses 40.86M67.67M88.90M119.30M131.13M125.90M350.00M72.70M315.70M198.70M453.80M532.00M122.50M151.60M257.50M309.70M
Operating Expenses 333.12M421.59M425.40M494.43M824.49M749.70M766.80M537.10M910.40M822.40M1,636.40M889.70M1,129.60M956.60M1,142.60M1,500.40M
Operating Income 25.76M171.31M317.78M421.65M292.50M538.80M699.00M1,061.70M814.90M805.40M-187.60M593.60M555.90M979.70M1,184.90M1,377.00M
EBIT 25.76M171.31M317.78M421.65M292.50M538.80M699.00M1,061.70M814.90M805.40M-187.60M593.60M555.90M979.70M1,184.90M1,377.00M
Non-operating items
Interest & Investment Income 5.15M2.94M3.45M3.94M3.83M3.50M10.90M28.60M44.20M28.60M16.70M45.20M162.70M199.10M
Other Non Operating Income 1.29M0.77M-1.93M35.66M4.46M4.00M0.10M-1.10M2.30M-7.70M22.60M49.30M42.20M-40.20M-14.00M5.80M
Non Operating Income -7.13M-16.16M-18.66M35.66M-13.60M-13.60M345.40M-1.50M-45.40M-46.50M22.60M49.30M42.20M-40.20M89.40M162.00M
Net income details
EBT 18.62M155.15M299.12M440.67M278.90M525.20M1,044.40M1,060.20M769.50M758.90M-165.00M638.90M593.90M950.60M1,274.30M1,539.00M
Tax Provisions 16.46M43.95M81.87M136.23M142.29M187.80M392.80M346.50M351.60M169.70M-60.50M124.10M118.10M223.30M289.50M343.90M
Profit After Tax 19.32M111.21M217.24M304.44M174.56M337.40M651.60M713.70M417.90M589.20M-104.50M514.80M475.80M727.30M984.80M1,195.10M
Equity Income -0.14M-0.16M-0.12M-0.14M
Income from Continuing Operations 2.16M111.21M217.24M304.44M136.61M337.40M651.60M713.70M417.90M589.20M-104.50M514.80M475.80M727.30M984.80M1,195.10M
Consolidated Net Income 0.14M-5.29M0.62M304.44M136.61M337.40M651.60M713.70M417.90M589.20M-104.50M514.80M475.80M727.30M984.80M1,195.10M
Income towards Parent Company 0.14M-5.29M0.62M304.44M136.61M337.40M651.60M713.70M417.90M589.20M-104.50M514.80M475.80M727.30M984.80M1,195.10M
Net Income towards Common Stockholders 19.46M105.92M217.87M304.44M174.56M340.10M651.60M713.70M417.90M589.20M-104.50M514.80M475.80M727.30M984.80M1,195.10M
Additional items
EPS (Basic) 0.371.983.815.843.497.0614.1716.299.5013.54-2.3911.6510.6015.9821.0426.44
EPS (Weighted Average and Diluted) 0.351.873.675.713.286.2812.7215.259.3113.39-2.3911.5410.0615.0019.8124.64
Shares Outstanding (Weighted Average) 53.84M56.92M53.63M50.80M50.23M47.51M45.63M42.42M43.21M43.72M43.88M44.44M45.04M45.58M46.99M44.64M
Shares Outstanding (Diluted Average) 56.13M59.52M44.00M43.80M44.60M47.30M48.50M49.70M48.50M
EBITDA 25.76M171.31M317.78M421.65M292.50M538.80M699.00M1,061.70M814.90M805.40M-187.60M593.60M555.90M979.70M1,184.90M1,377.00M
Interest Expenses 12.88M19.71M21.37M16.64M18.06M17.60M4.70M3.90M9.00M13.90M44.20M23.50M18.60M32.40M59.30M42.90M
Tax Rate 88.39%28.32%27.37%30.91%51.02%35.76%37.61%32.68%45.69%22.36%36.67%19.42%19.89%23.49%22.72%22.35%